Michael Hier
Overview
Explore the profile of Michael Hier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1017
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ducharme L, Lo C, Hier M, Zeitouni A, Kost K, Mlynarek A, et al.
Pilot Feasibility Stud
. 2024 Dec;
10(1):153.
PMID: 39709459
Background: This pilot study aimed to provide supportive evidence for the feasibility of conducting a full-scale intervention trial with patients newly diagnosed with head and neck cancer (HNC). This included...
2.
Sadeghi N, Subramaniam T, Richardson K, Mascarella M, Zeitouni A, Shenouda G, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 Dec;
151(2):128-134.
PMID: 39636629
Importance: Distant metastasis (DM) remains the leading cause of death in patients treated for human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). An effective treatment strategy needs to address DM...
3.
Nichols A, Theurer J, Prisman E, Read N, Berthelet E, Tran E, et al.
J Clin Oncol
. 2024 Sep;
42(34):4023-4028.
PMID: 39303189
Radiotherapy (RT) and transoral robotic surgery (TORS) are both curative-intent treatment options for oropharyngeal squamous cell carcinoma (OPSCC). Herein, we report the final outcomes of the ORATOR trial comparing these...
4.
Mascarella M, Vendra V, Sultanem K, Tsien C, Shenouda G, Sridharan S, et al.
J Geriatr Oncol
. 2024 Sep;
15(8):102064.
PMID: 39271411
Introduction: Frailty is a recognized condition associated with poorer outcomes in patients with head and neck cancer (HNC). The objective of this study was to ascertain the prognostic significance of...
5.
Henry M, Chen L, Ducharme L, Devault-Tousignant C, Rosberger Z, Frenkiel S, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 May;
150(7):598-606.
PMID: 38814668
Importance: Although patients with head and neck cancer (HNC) have been shown to experience high distress, few longitudinal studies include a comprehensive evaluation of biopsychosocial factors affecting quality of life...
6.
Muniz I, Araujo M, Bouassaly J, Farshadi F, Atique M, Esfahani K, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612819
The use of conventional chemotherapy in conjunction with targeted and immunotherapy drugs has emerged as an option to limit the severity of side effects in patients diagnosed with head and...
7.
Bouassaly J, Karimi N, Kowalski L, Sultanem K, Alaoui-Jamali M, Mlynarek A, et al.
Crit Rev Oncol Hematol
. 2024 Mar;
196:104326.
PMID: 38479584
Head and neck cancer (HNC) is the 6th most common cancer across the world, with a particular increase in HNC associated with human papilloma virus (HPV) among younger populations. Historically,...
8.
Mascarella M, Ferdus J, Vendra V, Sridharan S, Sultanem K, Tsien C, et al.
Head Neck
. 2024 Feb;
46(6):1500-1509.
PMID: 38353170
Sarcopenia is an increasingly recognized biomarker associated with poorer outcomes. The objective of this study was to ascertain the effect of sarcopenia on treatment tolerance and short-term toxicity in head...
9.
Atique M, Muniz I, Farshadi F, Hier M, Mlynarek A, Macarella M, et al.
Biomedicines
. 2024 Jan;
12(1).
PMID: 38275384
(1) Background: Head and neck cancer (HNC) ranks as the sixth most prevalent cancer in the world. In addition to the traditional risk factors such as alcohol and tobacco consumption,...
10.
Dayan G, Bahig H, Johnson-Obaseki S, Eskander A, Hong X, Chandarana S, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Jul;
149(11):961-969.
PMID: 37422839
Importance: Oral cavity cancer often requires multidisciplinary management, subjecting patients to complex therapeutic trajectories. Prolonged treatment intervals in oral cavity cancer have been associated with poor oncological outcomes, but there...